Pulmonary Function Testing (PFT) is
a complete assessment of respiratory system comprising patient history, chest
x-ray examinations, physical examinations, arterial blood gas analysis, and
tests of pulmonary function. Its primary
purpose is to identify the severity of pulmonary impairment & respiratory
issues. It is used to measure the rate of flow, gas exchange & lung volume
capacity. The testing systems help to diagnose lung disorders along with
treatment or therapeutics for lung disorders. It is normally performed by a
respiratory therapist, pulmonologist, physiotherapist, and/or general
practitioner.
Some of the risk associated with
PFT systems include dizziness during the tests, coughing, feeling short of
breath and asthma attack brought on by deep inhalation.
According to study, “Pulmonary
Function Testing Systems Market Research Report by Type (Complete PFT
Systems, Portable PFT Systems, and Others), Test Type (Spirometry, Lung Volume,
Gas Exchange Testing, and Others), Component (Software, Hardware, Service, and
Others), Application (Asthma, Chronic Shortness of Breath, Restrictive Lung
Disease, and Others), End-user (Hospital/Clinical Laboratories, Diagnostics
Laboratories, and Others), and Region-Global Forecast to 2023” the key
companies operating in the pulmonary function testing systems market are
Medical Equipment Europe GmbH, COSMED srl, Vyaire Medical, Inc., MGC,
Diagnostic Corporation, Schiller ECO MEDICS AG, Medical Electronic
Construction, CHEST M.I., Inc., NDD Medical Technologies.
Based on type, PFT system market is
segmented into portable PFT systems, complete PFT systems, and others. Based on
test type, market is segmented into lung volume test, spirometry test, gas
exchange testing, maximal voluntary ventilation, high altitude simulation
testing, oxygen titration test and others. The lung volume tests are tidal
volume (VT), expiratory reserve volume (ERV), inspiratory reserve volume (IRV),
and residual volume (RV). Based on techniques, market is segmented into
nitrogen washout, helium dilution and plethysmography. Based on applications,
market is segmented into asthma, restrictive lung disease, chronic shortness of
breath, chronic obstructive pulmonary disease, preoperative testing, early
morning wheezing, impairment or disability and others. In addition, based on
end-user, market is segmented into diagnostics laboratories, hospital/clinical
laboratories, and others.
The PFT system market is driven by
growth in an elderly population, followed by rise in prevalence of lung cancer
and increase in prevalence of respiratory diseases. However, rise in cost of
pulmonary devices and stringent regulatory policies may impact the market.
Moreover, environmental effects and change in life style are major
opportunities for market.
Based on geography, The America
region dominates the PFT system market followed by European region, owing to
growth in technological advancements in diagnostics, increase in prevalence of
lung diseases such as asthma, COPD, rise in prevalence of respiratory diseases
& other pulmonary disorders and surge in demand for lung function tests in
the region. The Asian-Pacific region is expected to be the fastest-growing
market due to growth in demand for pulmonary function testing devices in
private hospitals or clinics over the forecast period. Moreover, the Middle
East & Africa region is estimated to witness steady growth as a result of
rise in healthcare infrastructure and increase in demand for products during
the forecast period. It is predictable that the market will be reached at
speedy pace as a result of presence of a massive patient population during the
forecast period.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91
9015378249
